Your browser doesn't support javascript.
loading
Maintenance of response following discontinuation of guselkumab and secukinumab in Spanish patients who participated in the ECLIPSE study.
Rivera, R; Martorell, A; López, A; Salgado, L; Sahuquillo, A; de la Cueva, P; Herranz, P; Ratón, J A; Ferrán, M; Izu, R; Ruiz-Genao, D; García-Donoso, C; Carrascosa, J M.
Afiliação
  • Rivera R; Dermatology Department, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain.
  • Martorell A; Dermatology Department, Hospital de Manises, Valencia, Spain.
  • López A; Dermatology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Salgado L; Dermatology Department, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Spain.
  • Sahuquillo A; Dermatology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • de la Cueva P; Dermatology Department, Hospital Universitario Infanta Leonor, Madrid, Spain.
  • Herranz P; Dermatology Department, Hospital Universitario La Paz, Madrid, Spain.
  • Ratón JA; Dermatology Department, Hospital Universitario de Cruces, Bilbao, Spain.
  • Ferrán M; Dermatology Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain.
  • Izu R; Dermatology Department, Hospital de Basurto, Bilbao, Spain.
  • Ruiz-Genao D; Dermatology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
  • García-Donoso C; Dermatology Department, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain.
  • Carrascosa JM; Dermatology Department, Hospital Universitari Germans Trias i Pujol, Universidad Autónoma de Barcelona, Badalona, Barcelona, Spain.
J Eur Acad Dermatol Venereol ; 35(1): e65-e67, 2021 Jan.
Article em En | MEDLINE | ID: mdl-32648955

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Anticorpos Monoclonais Humanizados Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Anticorpos Monoclonais Humanizados Idioma: En Ano de publicação: 2021 Tipo de documento: Article